{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:23:39Z","timestamp":1782516219997,"version":"3.54.5"},"reference-count":74,"publisher":"Walter de Gruyter GmbH","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is a debilitating syndrome of unknown origin, characterized by profound postexertional malaise and fatigue, unrefreshing sleep, cognitive impairments, immune dysfunction, pain, autonomic dysfunction, and neuroendocrine symptoms. Although ME\/CFS is well documented within the medical literature, it remains difficult to diagnosis and manage. Some of the current challenges include an absence of diagnostic markers, differing diagnostic criteria, and an overall lack of awareness within the medical community. As a result, patients are often frustrated by the difficulties in acquiring a diagnosis and from the overall lack of available treatments. In an effort to increase awareness, this review discusses disease pathophysiology, clinical presentation, and treatment options, while also highlighting the benefits of an osteopathic approach.<\/jats:p>","DOI":"10.7556\/jaoa.2019.081","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T23:45:54Z","timestamp":1561419954000},"page":"446-455","source":"Crossref","is-referenced-by-count":6,"title":["Understanding Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome and the Emerging Osteopathic Approach: A Narrative Review"],"prefix":"10.1515","volume":"119","author":[{"given":"Christopher","family":"Larrimore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ramnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annmarie","family":"Jaghab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Sarduy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Troccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Bested","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"2022022617060419082_j_jaoa.2019.081_ref_001"},{"issue":"12","key":"2022022617060419082_j_jaoa.2019.081_ref_002","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_003","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: clinical working case definition, diagnostic and treatments protocols","volume":"11","author":"Carruthers","year":"2003","journal-title":"J Chronic Fatigue Syndr"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/occmed\/kqi013","article-title":"A systematic review describing the prognosis of chronic fatigue syndrome","volume":"55","author":"Cairns","year":"2005","journal-title":"Occup Med (Lond)"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-108-3-387","article-title":"Chronic fatigue syndrome: a working case definition","volume":"108","author":"Holmes","year":"1998","journal-title":"Ann Intern Med"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_006","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.13652796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"issue":"2","key":"2022022617060419082_j_jaoa.2019.081_ref_007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/014107689108400224","article-title":"A report\u2014 chronic fatigue syndrome: guidelines for research","volume":"84","author":"Sharpe","year":"1991","journal-title":"J Royal Society Med"},{"issue":"12","key":"2022022617060419082_j_jaoa.2019.081_ref_008","doi-asserted-by":"publisher","first-page":"860","DOI":"10.7326\/M15-0338","article-title":"National Institutes of Health Pathways to Prevention Workshop: advancing the research on myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"162","author":"Green","year":"2015","journal-title":"Ann Intern Med"},{"issue":"18","key":"2022022617060419082_j_jaoa.2019.081_ref_009","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/archinte.159.18.2129","article-title":"A community-based study of chronic fatigue syndrome","volume":"159","author":"Jason","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6","key":"2022022617060419082_j_jaoa.2019.081_ref_010","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-5918-7-6","article-title":"The economic impact of ME\/CFS: individual and societal costs","volume":"7","author":"Jason","year":"2008","journal-title":"Dyn Med"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_011","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1478-7547-2-4","article-title":"The economic impact of chronic fatigue syndrome","volume":"2","author":"Reynolds","year":"2004","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-7547-9-1","article-title":"The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs","volume":"9","author":"Lin","year":"2011","journal-title":"Cost Eff Resour Alloc"},{"issue":"2","key":"2022022617060419082_j_jaoa.2019.081_ref_013","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S0033291702006980","article-title":"The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care","volume":"33","author":"McCrone","year":"2003","journal-title":"Psychol Med"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_014","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.164.10.1098","article-title":"Disability and chronic fatigue syndrome: a focus on function.","volume":"164","author":"Ross","year":"2004","journal-title":"Arch Intern Med."},{"key":"2022022617060419082_j_jaoa.2019.081_ref_015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1472-6963-11-217","article-title":"The impact of CFS\/ME on employment and productivity in the UK: a cross-sectional study based on the CFS\/ME national outcomes database","volume":"11","author":"Collin","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1472-6963-10-56","article-title":"The hidden cost of chronic fatigue to patients and their families","volume":"10","author":"Sabes-Figuera","year":"2011","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"2022022617060419082_j_jaoa.2019.081_ref_017","first-page":"789","article-title":"A new clinical entity?","author":"Acheson","year":"1956","journal-title":"Lancet."},{"key":"2022022617060419082_j_jaoa.2019.081_ref_018","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jama.1964.03060250022005","article-title":"Epidemic neuromyasthenia. outbreak in a convent in New York state.","volume":"187","author":"Albrecht","year":"1964","journal-title":"JAMA."},{"issue":"8","key":"2022022617060419082_j_jaoa.2019.081_ref_019","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJM195708222570801","article-title":"Epidemic neuromyasthenia; an outbreak of poliomyelitis like illness in student nurses","volume":"257","author":"Shelokov","year":"1957","journal-title":"N Engl J Med"},{"issue":"7568","key":"2022022617060419082_j_jaoa.2019.081_ref_020","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Infection outcomes study","volume":"333","author":"Hickie","year":"2006","journal-title":"postinfective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-230X-12-13","article-title":"Chronic fatigue syndrome after giardia enteritis: clinical characteristics, disability and long-term sickness absence","volume":"12","author":"Naess","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_022","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-230X-13-28","article-title":"Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course","volume":"13","author":"M\u00f8rch","year":"2013","journal-title":"BMC Gastroenterolog"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_023","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2008-1879","article-title":"Chronic fatigue syndrome following infectious mononucleosis in adolescents.","volume-title":"Pediatrics","volume":"124","author":"Katz","year":"2009"},{"issue":"11","key":"2022022617060419082_j_jaoa.2019.081_ref_024","first-page":"3064","article-title":"Demonstration on Borna disease virus in patients with chronic fatigue syndrome [in Japanese]","volume":"55","author":"Nakaya","year":"1997","journal-title":"Nippon Rinsho"},{"issue":"10","key":"2022022617060419082_j_jaoa.2019.081_ref_025","first-page":"701","article-title":"Clinical characteristics of patients with chronic fatigue syndrome: analysis of 82 cases","volume":"85","author":"Li","year":"2005","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"2022022617060419082_j_jaoa.2019.081_ref_026","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/jcp.2004.020255","article-title":"The role of enterovirus in chronic fatigue syndrome","volume":"58","author":"Chia","year":"2005","journal-title":"J Clin Pathol"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_027","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2222\/jsv.55.9","article-title":"Human herpesvirus latency and fatigue [review]","volume":"55","author":"Kondo","year":"2005","journal-title":"Uirusu"},{"issue":"1E","key":"2022022617060419082_j_jaoa.2019.081_ref_028","first-page":"23","article-title":"Chronic fatigue syndromes: a preliminary overview [review].","volume":"17","author":"Komaroff","year":"1991","journal-title":"Can Dis Wkly Rep"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_029","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1093\/clinids\/18.Supplement_1.S130","article-title":"Viral studies of chronic fatigue syndrome.","volume":"18","author":"Ablashi","year":"1994","journal-title":"Clin Infect Dis."},{"issue":"9","key":"2022022617060419082_j_jaoa.2019.081_ref_030","doi-asserted-by":"crossref","first-page":"e0203503","DOI":"10.1371\/journal.pone.0203503","article-title":"Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_031","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40168-016-0171-4","article-title":"Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"4","author":"Giloteaux","year":"2016","journal-title":"Microbiome"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40168-017-0261-y","article-title":"Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"5","author":"Nagy-Szakal","year":"2017","journal-title":"Microbiome"},{"issue":"12","key":"2022022617060419082_j_jaoa.2019.081_ref_033","doi-asserted-by":"publisher","first-page":"e0145453","DOI":"10.1371\/journal.pone.0145453","article-title":"Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"10","author":"Shukla","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"2022022617060419082_j_jaoa.2019.081_ref_034","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2022022617060419082_j_jaoa.2019.081_ref_035","doi-asserted-by":"crossref","first-page":"e10817","DOI":"10.1371\/journal.pone.0010817","article-title":"Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV\/CD26","volume":"5","author":"Fletcher","year":"2010","journal-title":"PLoS ONE"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_036","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1479-5876-10-88","article-title":"Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"10","author":"Brenu","year":"2012","journal-title":"J Transl Med"},{"issue":"10","key":"2022022617060419082_j_jaoa.2019.081_ref_037","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.139.10.3306","article-title":"Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome","volume":"139","author":"Caligiuri","year":"1987","journal-title":"J Immunol"},{"issue":"8769","key":"2022022617060419082_j_jaoa.2019.081_ref_038","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","article-title":"Chronic fatigue syndrome: a clinical condition associated with immune activation","volume":"338","author":"Landay","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"2022022617060419082_j_jaoa.2019.081_ref_039","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1300\/J092v12n02_06","article-title":"Immunological changes after both exercise and activity in chronic fatigue syndrome: a pilot study","volume":"12","author":"White","year":"2004","journal-title":"J Chronic Fatigue Syndr"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_040","first-page":"94","article-title":"Altered immune response to exercise in patients with chronic fatigue syndrome\/ myalgic encephalomyelitis: a systematic review.","volume":"20","author":"Nijs","year":"2014","journal-title":"Exerc Immunol Rev."},{"key":"2022022617060419082_j_jaoa.2019.081_ref_041","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbacli.2014.04.001","article-title":"Association of mitochondrial dysfunction and fatigue: a review of the literature","volume":"1","author":"Filler","year":"2014","journal-title":"BBA Clin"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_042","first-page":"1","article-title":"Chronic fatigue syndrome and mitochondrial dysfunction","volume":"2","author":"Myhill","year":"2009","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_043","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11011-013-9435-x","article-title":"Mitochondrial dysfunctions in myalgic encephalomyelitis\/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways","volume":"29","author":"Morris","year":"2014","journal-title":"Metab Brain Dis"},{"issue":"2","key":"2022022617060419082_j_jaoa.2019.081_ref_044","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/jwh.2009.1507","article-title":"Postexertional malaise in women with chronic fatigue syndrome","volume":"19","author":"VanNess","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"2022022617060419082_j_jaoa.2019.081_ref_045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.mito.2011.05.005","article-title":"Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome","volume":"11","author":"Smits","year":"2011","journal-title":"Mitochondrion"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_046","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/cs0900295","article-title":"Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome","volume":"90","author":"McArdle","year":"1996","journal-title":"Clin Sci (Lond)"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_047","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2377-11-62","article-title":"Evidence for a heritable predisposition to chronic fatigue syndrome","volume":"11","author":"Albright","year":"2011","journal-title":"BMC Neurology"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_048","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1300\/J092v13n01_02","article-title":"Prevalence of chronic fatigue syndrome and chronic fatigue among family members of CFS patients","volume":"13","author":"Underhill","year":"2006","journal-title":"J Chronic Fatigue Syndr"},{"issue":"6","key":"2022022617060419082_j_jaoa.2019.081_ref_049","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00006842-200111000-00012","article-title":"A twin study of chronic fatigue","volume":"63","author":"Buchwald","year":"2001","journal-title":"Psychosom Med"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_050","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1038\/tp.2015.208","article-title":"Genome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"6","author":"Schlauch","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"3","key":"2022022617060419082_j_jaoa.2019.081_ref_051","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4236\/ojim.2013.33023","article-title":"Chronic fatigue syndrome with history of severe infection combined altered blood oxidant status, and reduced potassium efflux and muscle excitability at exercise","volume":"3","author":"Jammes","year":"2013","journal-title":"Open J Intern Med"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_052","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/reveh-2015-0026","article-title":"Review of myalgic encephalomyelitis\/chronic fatigue syndrome: an evidence-based approach to diagnosis and management by clinicians.","volume":"30","author":"Bested","year":"2015","journal-title":"Rev Environ Health."},{"issue":"19-20","key":"2022022617060419082_j_jaoa.2019.081_ref_053","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3109\/09638288.2010.546936","article-title":"Diagnostic accuracy of symptoms characterising chronic fatigue syndrome","volume":"33","author":"Davenport","year":"2011","journal-title":"Disabil Rehabil"},{"issue":"11","key":"2022022617060419082_j_jaoa.2019.081_ref_054","doi-asserted-by":"crossref","DOI":"10.2522\/ptj.20110368","article-title":"Discriminative validity of metabolic and workload measurements to identify individuals with chronic fatigue syndrome.","volume":"93","author":"Snell","year":"2013","journal-title":"Phys Ther."},{"key":"2022022617060419082_j_jaoa.2019.081_ref_055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1479-5876-10-88","article-title":"Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"10","author":"Brenu","year":"2012","journal-title":"J Transl Med"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_056","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.plefa.2003.12.015","article-title":"The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome","volume":"70","author":"Puri","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"2022022617060419082_j_jaoa.2019.081_ref_057","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/jcp.2006.042424","article-title":"Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome)","volume":"60","author":"Puri","year":"2007","journal-title":"J Clin Pathol"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_058","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/03009749709105320","article-title":"Increased concentrations of homocysteine in the cerebro-spinal fluid in patients with fibromyalgia and chronic fatigue syndrome","volume":"26","author":"Regland","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_059","doi-asserted-by":"publisher","first-page":"e0124648","DOI":"10.1371\/journal.pone.0124648","article-title":"Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia.","volume":"10","author":"Regland","year":"2015","journal-title":"PLoS One"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0031-9384(98)00145-0","article-title":"Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation.","volume":"65","author":"Lyte","year":"1998","journal-title":"Physiol Behav."},{"issue":"6","key":"2022022617060419082_j_jaoa.2019.081_ref_061","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbi.2007.02.005","article-title":"Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology","volume":"21","author":"Goehler","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_062","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1757-4749-1-6","article-title":"A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome","volume":"1","author":"Rao","year":"2009","journal-title":"Gut Pathog"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_063","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12967-018-1392-z","article-title":"Open-label pilot for treatment targeting guy dysbiosis in myalgic encephalomyelitis\/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons","volume":"16","author":"Wallis","year":"2018","journal-title":"J Transl Med"},{"issue":"10","key":"2022022617060419082_j_jaoa.2019.081_ref_064","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1517\/14656560902988510","article-title":"Pharmacological treatment of chronic fatigue syndrome focusing on the roles of antidepressants","volume":"10","author":"Pae","year":"2009","journal-title":"Expert Opin. Pharmacother"},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jama.280.4.372","article-title":"A 56-year-old woman with chronic fatigue syndrome, 1 year later.","volume":"280","author":"Delbanco","year":"1998","journal-title":"JAMA."},{"issue":"4","key":"2022022617060419082_j_jaoa.2019.081_ref_066","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-3223(91)90297-Y","article-title":"Nortriptyline in chronic fatigue syndrome: a double blind, placebo-controlled single case study","volume":"30","author":"Gracious","year":"1991","journal-title":"Biol Psychiatry"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_067"},{"issue":"3","key":"2022022617060419082_j_jaoa.2019.081_ref_068","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijosm.2010.12.002","article-title":"Muscle fatigue in chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) and its response to a manual therapeutic approach: a pilot study","volume":"14","author":"Perrin","year":"2011","journal-title":"Int J Osteopath Med"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_069","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijosm.2017.08.001","article-title":"Nociception, pain, neuroplasticity and the practice of osteopathic manipulative medicine","volume":"27","author":"Pelletier","year":"2018","journal-title":"Int J Osteopath Med"},{"issue":"7","key":"2022022617060419082_j_jaoa.2019.081_ref_070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1067\/mmt.2000.108821","article-title":"Do cerebral potentials to magnetic stimulation of paraspinal muscles reflect changes in palpable muscle spasm, low back pain, and activity scores?","volume":"23","author":"Zhu","year":"2000","journal-title":"J Manipulative Physiol Ther."},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_071","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmpt.2015.12.004","article-title":"Attenuation effect of spinal manipulation on neuropathic and postoperative pain through activating endogenous anti-inflammatory cytokine interleukin 10 in rat spinal cord","volume":"39","author":"Song","year":"2016","journal-title":"J Manipulative Physiol Ther"},{"issue":"1","key":"2022022617060419082_j_jaoa.2019.081_ref_072","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1443-8461(04)80003-0","article-title":"The effect of manipulation and mobilisation on pressure pain thresholds in the thoracic spine","volume":"7","author":"Fryer","year":"2004","journal-title":"J Osteopath Med"},{"issue":"11","key":"2022022617060419082_j_jaoa.2019.081_ref_073","doi-asserted-by":"publisher","first-page":"874","DOI":"10.7556\/jaoa.2014.173","article-title":"Osteopathic manipulative treatment for postural orthostatic tachycardia syndrome","volume":"114","author":"Goodkin","year":"2014","journal-title":"J Am Osteopath Assoc"},{"key":"2022022617060419082_j_jaoa.2019.081_ref_074","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijosm.2017.08.001","article-title":"Nociception, pain, neuroplasticity and the practice of osteopathic manipulative medicine","volume":"27","author":"Pelletier","year":"2018","journal-title":"Int J Osteopath Med"}],"container-title":["The Journal of the American Osteopathic Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2019.081\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2019.081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T18:40:38Z","timestamp":1694976038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2019.081\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7,1]]}},"alternative-id":["10.7556\/jaoa.2019.081"],"URL":"https:\/\/doi.org\/10.7556\/jaoa.2019.081","relation":{},"ISSN":["1945-1997","0098-6151"],"issn-type":[{"value":"1945-1997","type":"electronic"},{"value":"0098-6151","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}